|
Study type |
Subjects division | Population | Vitamin D assessment/supplement | Duration | Conclusion | Citation |
|
Prospective | Female Male | 28 32 | Iranian | Vitamin D assessment, P-selectin, and hs-CRP levels measurement for thrombosis condition | 3 months | Did not find significant relationship between Vitamin D and P-selectin and hs-CRP levels | [120] |
|
Cross-sectional | Postmenopausal women | 926 | Chinese | Vitamin D assessment & carotid IMT measurement | | Serum 25(OH)D inversely correlated with carotid IMT | [115] |
|
Cross-sectional | Female (43%), male (57%) | 567 | | Vitamin D assessment, arterial stiffness, and carotid IMT | | Nonlinear relationship between 25(OH)D and IMT, and IMT increases slightly for 25(OH)D levels above 50 nmol/L | [117] |
|
Prospective |
2148 | Finnish | Vitamin D assessment & carotid IMT measurement | 27 years | Low Vitamin D levels were associated with increased carotid IMT in adulthood | [116] |
|
Cross-sectional | T2DM | 352 | Chinese | Vitamin D assessment, carotid plaques, and carotid IMT | | Serum Vitamin D independently associated with carotid atherosclerosis in T2D | [113] |
|
Randomized controlled | T2D | 415 | Danish | Vitamin D assessment, carotid IMT and arterial stiffness markers, and DXA scan | 4 years | 25(OH)D status not associated with carotid IMT, arterial thickness, or bone health | [106] |
|
Cross-sectional | Control Case (atherosclerosis) | 110 98 | | Vitamin D assessment & coronary CT angiography | | Relationship between low Vitamin level and coronary atherosclerosis and plaque burden, but not with morphology | [101] |
|
Randomized controlled | Placebo Case (atorvastatin) | 103 98 | Diverse | Vitamin D assessment, carotid IMT progression, and secondary outcomes (cholesterol, LDL, and hs-CRP) | 3 years | Baseline 25(OH)D levels ≥21 ng/mL associated with lower baseline hs-CRP levels. Vitamin D deficiency may be involved in response to atorvastatin | [100] |
|
Randomized controlled | Placebo Case-supplement | 100 100 | Austria | Vitamin D supplementation for cases, 2800 IU of Vitamin D3/day for 8 weeks | | Supplementation for hypertensive patients with low serum levels has no significant effect on blood pressure | [91] |
|
Prospective | White (76%), Black (24%) | 12215 | Diverse | Vitamin D assessment | 21 years | Association between Vitamin D and risk of heart failure found for both Black and White people, but in White people it also reflected incidence of heart failure | [89] |
|
Cross-sectional | Controls Case (stroke patients) | 70 73 | Indian | Vitamin D assessment, iPTH levels, and risk factors of stroke | | Vitamin D deficiency is not linked with ischemic stroke or its risk factors | [87] |
|
Prospective | Female Male | 2007 1388 | Netherlands | Assessment of Vitamin D, Atrial Fibrillation (AF), and confounders | 12 years | Vitamin D status was not associated with AF incidence | [82] |
|
Cohort |
9949 | German | Vitamin D assessment and fatal and nonfatal CVD incidence | 5 years | Relationship suggests that low 25(OH)D levels moderately increase risk of CVD, much strongly for fatal incidences | [80] |
|
Prospective Mendelian |
95766 | Danish | Vitamin D assessment, genotypes for DHCR7 & CYP2R1, and mortality confounders | 5–19 years | Vitamin D concentration not associated with CVD mortality but could be result of confounding factors | [68] |
|
Cross-sectional | Without plaque With plaque | 712 289 | Chinese | Vitamin D assessment, carotid plaque, and carotid IMT | | Serum Vitamin D levels are inversely associated with atherosclerosis. Vitamin D is also a protective factor for increased carotid IMT amongst subjects with plaque | [11] |
|
Prospective |
12158 | | Vitamin D assessment, stroke incidence, and rs7041, rs4588 SNPs for D binding protein were genotyped | 20 years | Low 25(OH)D levels are risk factor for stroke, especially those predisposed to high DBP | [10] |
|